Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

A glucose-dependent panhemagglutinin

T Lewis, M Reid, S Ellisor

    Vox Sanguinis
    |October 1, 1980
    PubMed
    Summary
    This summary is machine-generated.

    A novel agglutinin was found that reacts with glucose-coated red blood cells, not typical antibodies. This discovery may mislead blood transfusion services by mimicking high-frequency antigen antibodies.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    First Evidence for Mixing-Induced CP Violation in B_{s}^{0}→J/ψϕ(1020) Decays in pp Collisions at sqrt[s]=13  TeV.

    Physical review letters·2026
    Same author

    Measurement of D^{0} Meson Photoproduction in Ultraperipheral Heavy Ion Collisions.

    Physical review letters·2026
    Same author

    Observation of Coherent ϕ(1020) Meson Photoproduction in Ultraperipheral PbPb Collisions at sqrt[s_{NN}]=5.36  TeV.

    Physical review letters·2026
    Same author

    Search for New Physics in Jet Multiplicity Patterns of Multilepton Events at sqrt[s]=13  TeV.

    Physical review letters·2025
    Same author

    Search for the Rare Decay D^{0}→μ^{+}μ^{-} in Proton-Proton Collisions at sqrt[s]=13.6  TeV.

    Physical review letters·2025
    Same author

    Observation of Λ Hyperon Local Polarization in p-Pb Collisions at sqrt[s_{NN}]=8.16  TeV.

    Physical review letters·2025
    Same journal

    Red cell alloantibodies in 71,525 Malaysian blood donations: Predominance of anti-Mia reflects GP.Mur-associated antigenic diversity.

    Vox sanguinis·2026
    Same journal

    Barriers and enablers to non-remunerated plasma donation: A meta-synthesis of the qualitative literature using the theoretical domains framework.

    Vox sanguinis·2026
    Same journal

    Haemolytic disease of the foetus and newborn due to anti-M: A systematic review.

    Vox sanguinis·2026
    Same journal

    In vitro evaluation of apheresis platelet and plasma products collected and stored in non-DEHP disposable sets.

    Vox sanguinis·2026
    Same journal

    Survey of national and regional rare donor programmes regarding Immunoglobulin A deficiency.

    Vox sanguinis·2026
    Same journal

    Fibrinogen recovery in cryoprecipitate prepared from thawed plasma stored for 5 days post-thaw.

    Vox sanguinis·2026
    See all related articles

    Area of Science:

    • Immunology
    • Transfusion Medicine
    • Biochemistry

    Background:

    • Identification of unusual agglutinins in patient serum is crucial for transfusion safety.
    • Understanding non-antibody-mediated red blood cell agglutination is essential for accurate laboratory diagnostics.

    Observation:

    • An agglutinin in a patient's serum reacted with all commercial red blood cells after incubation with glucose.
    • Red blood cells incubated with glucose showed increased agglutinability, which diminished upon washing and incubation in saline.
    • The agglutinin's reactivity was inhibited by glucose but not other sugars, and it was sensitive to 2-mercaptoethanol but heat-stable at 56°C.

    Findings:

    • A glucose-specific agglutinin, distinct from typical antibodies, was characterized.
    • The agglutinin's properties suggest a non-immunoglobulin nature, possibly protein-based, interacting with glucose-modified red blood cells.

    Related Experiment Videos

  • The agglutinin demonstrated significant titer in both LISS and saline media.
  • Implications:

    • This finding highlights a potential diagnostic challenge in blood transfusion laboratories, mimicking antibodies against high-incidence antigens.
    • Awareness of such glucose-dependent agglutinins is necessary to prevent misdiagnosis and ensure patient safety.
    • Further research into the exact nature and mechanism of this agglutinin is warranted.